Advertisement

Ads Placeholder
Loading...

Biotest AG

BIO1.F•XETRA
Healthcare
Drug Manufacturers - Specialty & Generic
€36.60
€0.00(0.00%)
German Market opens in 1h 6m

Biotest AG (BIO1.F) Stock Overview

Explore Biotest AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-42.67
EPS (TTM)$-1.60
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BIO1.F Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biotest AG (BIO1.F) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -42.67 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.biotest.com
49 61 03 801 0
Landsteinerstrasse 5, Dreieich, NaN, 63303

Company Facts

19,670 Employees
CountryDE

Frequently Asked Questions